Champions Oncology Inc Stock
Your prediction
Champions Oncology Inc Stock
We can see a decrease in the price for Champions Oncology Inc. Compared to yesterday it has lost -€0.060 (-1.220%).
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | -1.220% | -2.410% | -19.669% | -49.110% | -16.207% | 12.500% | -49.375% |
| Heron Therapeutics Inc. | 1.690% | -0.394% | -9.571% | -57.449% | -9.246% | -53.624% | -93.267% |
| Evolus Inc | -4.740% | -2.162% | -8.586% | -72.366% | -33.578% | -56.905% | -64.786% |
| Sangamo Therapeutics Inc. | -2.930% | 14.215% | -18.135% | -62.306% | 5.432% | -86.736% | -96.300% |
News
3 Dividend Champions to Buy and Hold for Decades
There's a saying on Wall Street that "dividends don't lie." Just about every financial metric can be spun by a company's management, but dividends either arrive in the mail or they don't. Companies
3 Dividend Champion Stocks I'm Watching in 2025
If you are looking for high-yield stocks in a stock market that is hovering near all-time highs, a good place to start your search is with reliable dividend payers.
Dividend Champions fit the bill